Nasreen, A., Vogt, M., Kim, H.J., Eichinger, A., Skerra, A. (2006) Solubility engineering and crystallization of human apolipoprotein D. Protein Sci. 15(1), 190-199.
Monday, June 23, 2025 BiopharmaWatch Research 1 min read
Key Takeaway: The article discusses solubility engineering and crystallization of human apolipoprotein D, as detailed in a study by Nasreen et al. The research is published in Protein Science and focuses on methods to enhance protein solubility and crystallization techniques. This work contributes to the understanding of protein behavior in biological systems.
Price reaction · baseline $22.05 (2025-06-20 close) · 9 other PVLA headline(s) in the window, move may be shared
day 0 close · peak
+2.2%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+106%
120-day peak, hindsight
Typical move
8.9%
average across 5 past catalysts
Cash runway
~58 mo
Minimal dilution risk
Lead asset
PTX-022
Phase 3 · Pachyonychia Congenita
Full Press Release Details
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.